Delivery Order SPE2DB22D2206-SPE2DB25FFG18

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,001.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINISOL 15% SOLUTION 2000ML, a medical supply, with a completion date of June 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $7,206.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for CLINISOL 15% SOLUTION 2000ML, with an ultimate completion date of October 23, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $9,829.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINISOL 15% SOLUTION 2000ML, a medical product, with a period of performance through February 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CLINISOL 15% SOLUTION 2000ML. The contract has a firm fixed price of $4,361.02 and a completion date of August 7, 2024. The award is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CLINISOL 15% SOLUTION 2000ML medical supplies. The contract has a ceiling value of $1,587.92 and is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDUB0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,389.60 Firm Fixed Price Delivery Order contract is for the supply of CLINISOL 15% SOLUTION 2000ML medical products, with a period of performance through January 14, 2025. The contract was awarded on January 13, 2025 and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,011.50 firm-fixed-price delivery order is for the supply of CLINISOL 15% SOLUTION 2000ML medical products. The contract has a completion date of January 11, 2024 and was awarded on January 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,489.91, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical program, valued at $999,999,999. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $4,325.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, valued at $4,183.55, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFG18
    Delivery Order

This federal contract award, worth $4,493.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINISOL 15% SOLUTION 2000ML, a medical product, with a completion date of January 28, 2025.

The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/28/25, 9:50 AM